Atrium Therapeutics Inc (RNA)

Working Capital Ratio

86.82%

Quarterly · Period ending:

RNA logo

RNA Working Capital Ratio

Latest reported86.82%
RNA Quarterly Working Capital Ratio (86.30% → 86.82%)
High-resolution chart · PNG

RNA working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
86.8209%
90.1833%
83.004%
86.3009%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.